Updating the natural history of hpv and anogenital cancer

Volume 100 of the IARC Monographs, A Review of Human Carcinogens, covers all agents previously classified by IARC as "carcinogenic to humans (Group 1)".

This Volume 100B covers Human Papillomaviruses, among other Biological Agents.

It focuses primarily on the prevention of cervical cancer, but also adresses the broader spectrum of cancers and other diseases preventable by HPV vaccination.

The main difference from the previous paper concerns the number of doses of vaccine recommended for different age groups.

The current prophylactic HPV VLP vaccines are delivered i.m.

circumventing the intra-epithelial immune evasion strategies. These vaccines generate high levels of antibody and both serological and B cell memory as evidenced by persistence of antibody and robust recall responses.

It could be something as simple as a run away script or learning how to better use E-utilities, for more efficient work such that your work does not impact the ability of other researchers to also use our site.This publication, Comprehensive cervical cancer control: a guide to essential practice (C4GEP), provides a comprehensive approach to cervical cancer prevention and control.In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the need for collaboration across programmes, organizations and partners.This is a special supplement on HPV disease and prevention authored by scientists and experts in the field that updates previous reviews (20).The supplement is presented as individual peer-reviewed articles on HPV as a major public health problem, including: HPV natural history and biology, HPV therapies, current screening strategies for cervical cancer including new technologies and prospects, prophylactic HPV vaccines and their introduction, economic analyses and gaps in knowledge.